Tibet Weixinkang Medicine Co., Ltd. (603676.SS) SHH
10.30
-0.1(-0.96%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
10.30
-0.1(-0.96%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
689
First IPO Date
July 21, 2017
| Name | Title | Pay | Year Born |
| Haibo Yu | Board Secretary | 0 | 1979 |
| Shigong Chen | Deputy GM & Director | 0 | 1973 |
| Xiaobing Zhou | Deputy General Manager | 0 | 1976 |
| Liqun Yao | Accounting Supervisor | 0 | N/A |
| Feng Liu | Vice Chairman & Deputy GM | 0 | 1973 |
| Zizhong Weng | Deputy General Manager | 0 | 1964 |
| Yong Zhang | Chairman of the Board & GM | 0 | 1972 |
| Yanxia Zheng | Financial Director | 0 | 1979 |
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company's products include parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is based in Lhasa, China.